| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |